SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the COVID-19 pandemic. However, the recently emerged SARS-CoV-2 variants B.1.1.7 (UK), B.1.351 (South Africa), and P.1 (Brazil) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Markus, Arora, Prerna, Groß, Rüdiger, Seidel, Alina, Hörnich, Bojan F., Hahn, Alexander S., Krüger, Nadine, Graichen, Luise, Hofmann-Winkler, Heike, Kempf, Amy, Winkler, Martin S., Schulz, Sebastian, Jäck, Hans-Martin, Jahrsdörfer, Bernd, Schrezenmeier, Hubert, Müller, Martin, Kleger, Alexander, Münch, Jan, Pöhlmann, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980144/
https://www.ncbi.nlm.nih.gov/pubmed/33794143
http://dx.doi.org/10.1016/j.cell.2021.03.036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980144/
https://www.ncbi.nlm.nih.gov/pubmed/33794143
http://dx.doi.org/10.1016/j.cell.2021.03.036

Ejemplares similares